Telemus Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-993
| Closed | -$457K | – | 328 |
|
2023
Q1 | $457K | Sell |
993
-16
| -2% | -$7.36K | 0.04% | 227 |
|
2022
Q4 | $480K | Buy |
1,009
+101
| +11% | +$48K | 0.04% | 228 |
|
2022
Q3 | $412K | Sell |
908
-206
| -18% | -$93.5K | 0.04% | 220 |
|
2022
Q2 | $538K | Sell |
1,114
-345
| -24% | -$167K | 0.05% | 232 |
|
2022
Q1 | $717K | Sell |
1,459
-8
| -0.5% | -$3.93K | 0.06% | 201 |
|
2021
Q4 | $680K | Buy |
1,467
+25
| +2% | +$11.6K | 0.05% | 213 |
|
2021
Q3 | $538K | Hold |
1,442
| – | – | 0.05% | 229 |
|
2021
Q2 | $551K | Buy |
1,442
+20
| +1% | +$7.64K | 0.04% | 233 |
|
2021
Q1 | $505K | Sell |
1,422
-75
| -5% | -$26.6K | 0.03% | 270 |
|
2020
Q4 | $481K | Hold |
1,497
| – | – | 0.04% | 261 |
|
2020
Q3 | $444K | Buy |
1,497
+35
| +2% | +$10.4K | 0.03% | 325 |
|
2020
Q2 | $373K | Hold |
1,462
| – | – | 0.03% | 310 |
|
2020
Q1 | $430K | Sell |
1,462
-178
| -11% | -$52.4K | 0.04% | 268 |
|
2019
Q4 | $495K | Sell |
1,640
-200
| -11% | -$60.4K | 0.04% | 249 |
|
2019
Q3 | $442K | Sell |
1,840
-23
| -1% | -$5.53K | 0.04% | 259 |
|
2019
Q2 | $528K | Sell |
1,863
-300
| -14% | -$85K | 0.05% | 231 |
|
2019
Q1 | $621K | Sell |
2,163
-2,455
| -53% | -$705K | 0.05% | 247 |
|
2018
Q4 | $1.21M | Sell |
4,618
-101
| -2% | -$26.5K | 0.1% | 153 |
|
2018
Q3 | $1.29M | Sell |
4,719
-3,260
| -41% | -$893K | 0.1% | 160 |
|
2018
Q2 | $1.9M | Buy |
7,979
+735
| +10% | +$175K | 0.15% | 126 |
|
2018
Q1 | $1.59M | Sell |
7,244
-87
| -1% | -$19.1K | 0.13% | 144 |
|
2017
Q4 | $1.65M | Buy |
7,331
+644
| +10% | +$145K | 0.13% | 137 |
|
2017
Q3 | $1.27M | Sell |
6,687
-2,742
| -29% | -$521K | 0.14% | 111 |
|
2017
Q2 | $1.77M | Buy |
9,429
+397
| +4% | +$74.7K | 0.18% | 97 |
|
2017
Q1 | $1.49M | Buy |
9,032
+3,037
| +51% | +$502K | 0.16% | 107 |
|
2016
Q4 | $862K | Sell |
5,995
-433
| -7% | -$62.3K | 0.12% | 136 |
|
2016
Q3 | $805K | Buy |
6,428
+1,880
| +41% | +$235K | 0.09% | 165 |
|
2016
Q2 | $597K | Buy |
4,548
+2,200
| +94% | +$289K | 0.07% | 189 |
|
2016
Q1 | $326K | Buy |
+2,348
| New | +$326K | 0.05% | 243 |
|